Very long‐term survivors among patients with metastatic soft tissue sarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Very long‐term survivors among patients with metastatic soft tissue sarcoma

Published:2019-03-27 Issue:4 Volume:8 Page:1368-1378
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Carbonnaux Mélodie¹²^ORCID,Brahmi Mehdi¹²,Schiffler Camille³,Meeus Pierre⁴,Sunyach Marie‐Pierre¹²,Bouhamama Amine⁵,Karanian Marie⁶,Tirode Franck⁷,Pissaloux Daniel⁶,Vaz Gualter⁴,Ray‐Coquard Isabelle¹²,Blay Jean‐Yves¹²,Dufresne Armelle¹²

Affiliation:

1. Department of Medical Oncology Centre Léon Bérard Lyon France

2. Université Claude Bernard Lyon France

3. Department of Clinical Research Centre Léon Bérard Lyon France

4. Department of Surgery Centre Léon Bérard Lyon France

5. Department of Radiology Centre Léon Bérard Lyon France

6. Department of Biopathology Centre Léon Bérard Lyon France

7. Department of Translational Research and Innovation Centre Léon Bérard Lyon France

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.1931

Reference18 articles.

1. Soft tissue and visceral sarcomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

2. Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical trials 62043 and 62072

3. Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

4. Prognostic and predictive factors for outcome to first-line ifosfamide-containing chemotherapy for adult patients with advanced soft tissue sarcomas

5. Prognostic factors in soft tissue sarcomas: a study of 395 patients

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epithelioid hemangio-endothelioma (EHE) in NETSARC: The nationwide series of 267 patients over 12 years;European Journal of Cancer;2023-10

2. Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial;The Lancet Oncology;2023-08

3. Local Therapies for Metastatic Sarcoma: Why, When, and How?;American Society of Clinical Oncology Educational Book;2023-06

4. Future trends in incidence and long-term survival of metastatic cancer in the United States;Communications Medicine;2023-05-27

5. Oncostatin M and Nivolumab Affect the Cytotoxic T-Cell Proportions and the Susceptibility to TRAIL-Induced Death in Non-Leukocyte Cell Subpopulations in Soft Tissue Sarcomas;Pharmacology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3